phenobarbital tablet
american health packaging - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 32.4 mg
phenobarbital tablet
bryant ranch prepack - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 16.2 mg
phenobarbital tablet
remedyrepack inc. - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 16.2 mg
phenobarbital tablet
cardinal health - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 16.2 mg
phenobarbital tablet
mckesson contract packaging - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital 15 mg
phenobarbital 200mg/1ml solution for injection ampoules
martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 200mg/1ml
phenobarbital 15mg/5ml elixir
thornton & ross ltd - phenobarbital - oral solution - 3mg/1ml
phenobarbital 60mg/1ml solution for injection ampoules
martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 60mg/1ml
phenobarbital 30mg/1ml solution for injection ampoules
martindale pharmaceuticals ltd - phenobarbital sodium - solution for injection - 30mg/1ml
phenobarbital tablet
remedyrepack inc. - phenobarbital (unii: yqe403bp4d) (phenobarbital - unii:yqe403bp4d) - phenobarbital tablets, usp are indicated for use as a sedative or anticonvulsant. phenobarbital is contraindicated in patients who are hypersensitive to barbiturates. in such patients, severe hepatic damage can occur from ordinary doses and is usually associated with dermatitis and involvement of parenchymatous organs. a personal or familial history of acute intermittent porphyria represents one of the few absolute contraindications to the use of barbiturates. phenobarbital is also contraindicated in patients with marked impairment of liver function, or respiratory disease in which dyspnea or obstruction is evident. it should not be administered to persons with known previous addiction to the sedative/hypnotic group, since ordinary doses may be ineffectual and may contribute to further addiction. controlled substance: phenobarbital is a schedule iv drug. prolonged, uninterrupted use of barbiturates (particularly the short-acting drugs), even in therapeutic doses, may result in psychic and physical dependence